In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.

Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a particular point in time or over a designated period. It reflects how widespread the disease is within the population and is typically expressed as a percentage or as the number of cases per a set number of individuals (e.g., per 1,000 or 100,000 people).

Prevalence also provides insight into the overall burden of disease in a population, making it essential for planning healthcare resources and services. However, it does not indicate the risk of developing the disease or the rate at which it is spreading.

Incidence, by contrast, measures the rate at which new cases of a disease occur in a population over a specified time period. This metric focuses on new cases, offering insight into the risk of contracting the disease and the dynamics of its spread.

Generally, incidence can be expressed in two ways:

  1. Incidence Rate (or Incidence Density): The number of new cases per person-time at risk (e.g., per 1,000 person-years).
  2. Cumulative Incidence (or Incidence Proportion): The proportion of an initially disease-free population that develops the disease over a specified period (e.g., the percentage of people who develop the disease within one year).

Incidence is crucial for understanding disease transmission dynamics and for assessing the effectiveness of preventive measures aimed at reducing new cases.

While prevalence and incidence are related, they capture different aspects of disease presence. Incidence focuses on the occurrence of new cases, while prevalence encompasses all existing cases. The prevalence of a disease in a population is influenced by both the incidence rate and the disease duration. For long-duration diseases, prevalence can remain high even if the incidence is low. Conversely, for diseases of short duration, prevalence may be low despite a high incidence rate.

Z rozdziału 14:

article

Now Playing

14.3 : Prevalence and Incidence

Biostatistics

155 Wyświetleń

article

14.1 : Przegląd biostatystyki w naukach o zdrowiu

Biostatistics

166 Wyświetleń

article

14.2 : Wprowadzenie do epidemiologii

Biostatistics

216 Wyświetleń

article

14.4 : Czułość, swoistość i przewidywana wartość

Biostatistics

61 Wyświetleń

article

14.5 : Wykres charakterystyki pracy odbiornika

Biostatistics

38 Wyświetleń

article

14.6 : Projekty badań w epidemiologii

Biostatistics

55 Wyświetleń

article

14.7 : Metodologia powierzchni odpowiedzi

Biostatistics

20 Wyświetleń

article

14.8 : Ryzyko względne

Biostatistics

30 Wyświetleń

article

14.9 : Iloraz szans

Biostatistics

25 Wyświetleń

article

14.10 : Związek przyczynowo-skutkowy w epidemiologii

Biostatistics

42 Wyświetleń

article

14.11 : Mylące w badaniach epidemiologicznych

Biostatistics

57 Wyświetleń

article

14.12 : Strategie oceny i przeciwdziałania zakłóceniom

Biostatistics

49 Wyświetleń

article

14.13 : Kryteria związku przyczynowo-skutkowego: Kryteria Bradforda Hilla - I

Biostatistics

32 Wyświetleń

article

14.14 : Kryteria związku przyczynowego: Kryteria Bradforda Hilla - II

Biostatistics

23 Wyświetleń

article

14.15 : Stronniczość w badaniach epidemiologicznych

Biostatistics

45 Wyświetleń

See More

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone